Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 effect on insulin biosynthesis in type 2 diabetes
NCT00609154Phase 2Terminated
- Sponsor
- Albert Einstein College of Medicine
- Start
- Aug 2010
- Primary completion
- May 2014
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of Glucagon-like peptide 1 in type 2 diabetes mellitus (T2DM), sponsored by Albert Einstein College of Medicine. Started Aug 2010; status: terminated.
02
Drugs
Glucagon-like peptide 1
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00609154.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00609154.